Skip to content
OpenCapital
Get started

Bruker BRKR Bsi Biospin — Research And Development Expense

Other segment segments

Bsi Nano
$42.9M-5.3%
Bsi Calid
$33.1M+18.6%
Energy And Supercon Technologies
$800K+33.3%

Similar metrics at other companies

TEC
TECHDiagnostics And Spatial Biology — Research And Development Expense Excluding Acquired In Process Cost
$9M-11.7%
Biogen logo
BIIBReportable Segment — Research and development:
$172.8M-3.2%
Biogen logo
BIIBSPINRAZA — Research And Development Expense Excluding Acquired In Process Cost
$8.83M—
Boston Scientific logo
BSXCardiovascular — Research and development expenses
$343M+21.2%
Neurocrine Biosciences logo
NBIXReportable Segment — R&D
$296.2M+12.5%
ImmunityBio, Inc. logo
IBRXReportable Segment — R&D
$67.99M+41.0%

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's bsi biospin — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's bsi biospin — research and development expense?
Bruker (BRKR) reported bsi biospin — research and development expense of $24.2M in Q1 2026.
How has Bruker's bsi biospin — research and development expense changed year-over-year?
Bruker's bsi biospin — research and development expense increased by 10.0% year-over-year, from $22M to $24.2M.
What is the long-term trend for Bruker's bsi biospin — research and development expense?
Over 3 years (2022 to 2025), Bruker's bsi biospin — research and development expense has grown at a 11.6% compound annual growth rate (CAGR), from $67.4M to $93.7M.
What does bsi biospin — research and development expense mean?
The amount spent by the BioSpin segment on developing new products and improving existing technologies.
How do you interpret bsi biospin — research and development expense?
An increase signals a focus on future growth and innovation, while a significant decrease may indicate a reduction in long-term competitiveness.
How does bsi biospin — research and development expense compare across companies?
Standard R&D expenditure metric for technology and life science companies.